Want to see SMMT full AI Analyst Report?
Summit Therapeutics (SMMT) Financial Statements
2,035 Followers
Summit Therapeutics Financial Overview
Summit Therapeutics's market cap is currently £11.84B. The company's EPS TTM is £-1.12; its P/E ratio is -14.11; Summit Therapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | £ 0.00 | £ 0.00 | £ 0.00 | £ 583.19K | £ 1.34M |
| Gross Profit | £ 0.00 | £ 0.00 | £ 0.00 | £ 583.19K | £ 1.34M |
| Operating Income | £ -1.09B | £ -180.51M | £ -478.23M | £ -59.63M | £ -63.73M |
| EBITDA | £ -1.08B | £ -168.44M | £ -69.41M | £ -51.37M | £ -62.86M |
| Net Income | £ -1.08B | £ -176.77M | £ -482.37M | £ -65.17M | £ -65.52M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | £ 529.49M | £ 329.50M | £ 147.38M | £ 284.18M | £ 53.22M |
| Total Assets | £ 557.50M | £ 348.05M | £ 160.60M | £ 541.43M | £ 84.04M |
| Total Debt | £ 15.50M | £ 5.77M | £ 83.96M | £ 422.89M | £ 2.06M |
| Net Debt | £ -151.68M | £ -78.03M | £ 27.44M | £ 138.71M | £ -51.15M |
| Total Liabilities | £ 68.52M | £ 37.41M | £ 99.12M | £ 438.18M | £ 22.30M |
| Stockholders' Equity | £ 488.98M | £ 310.64M | £ 61.48M | £ 103.25M | £ 61.74M |
| Cash Flow | |||||
| Free Cash Flow | £ -240.15M | £ -113.67M | £ -60.85M | £ -34.41M | £ -54.03M |
| Operating Cash Flow | £ -239.67M | £ -113.56M | £ -60.74M | £ -33.90M | £ -53.81M |
| Investing Cash Flow | £ -129.37M | £ -164.09M | £ -465.14M | £ -508.68K | £ -226.83K |
| Financing Cash Flow | £ 458.31M | £ 304.63M | £ 68.46M | £ 505.62M | £ 57.76M |
Currency in GBP
